Saniona – FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity
Rami Levin, President and CEO of Saniona discusses Tesomet, the first and only investigational treatment for Hypothalamic Obesity (HO) to receive orphan...
176 articles
Rami Levin, President and CEO of Saniona discusses Tesomet, the first and only investigational treatment for Hypothalamic Obesity (HO) to receive orphan...
Larry Edwards, MD, MACP, MACR, rheumatologist and Chairman of the Gout Education Society discusses managing gout during the summer, with travel and g...
Clive Ward-Able is the Medical & Scientific Affairs Consultant of NeonMind Biosciences, a company exploring psilocybin as an alternative approach to wei...
For many, the pandemic is a wake-up call to pay attention to our mental and physical health. Obesity is a disease that's tied to serious health risks ...
Mark Allen, MD, co-founder and CEO of Elevian, developer of therapies to treat age-related diseases like stroke and diabetes, discusses the drug candida...
Jacob Teitelbaum discusses a recent study published in the "American Journal of Clinical Pathology" (Nov 2020) that showed that 59 percent of patients w...
Matt Kuchan, PhD, Research Fellow and discovery scientist in Research and Development, the global brain health platform and science lead for Abbott's ...
Pam Nisevich Bede, a registered dietitian from Abbott, a global healthcare company and leader in nutrition science, discusses how to get “nutrition st...
Cedric Bryant, Ph.D., Chief Science Officer at the American Council on Exercise (ACE) discusses ACE's behavior change research-based philosophy called t...
Andrew Chan, Chief of Clinical and Translational Epidemiology Unit at Massachusetts General Hospital discusses the presentation from Digestive Disease W...